Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    Open Studies | "Pituitary Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery
Condition: Pituitary Neoplasms
Interventions: Drug: Dexmedetomidine;   Drug: Sodium Chloride 0.9%
2 Recruiting Ga-68-DOTATOC -PET in the Management of Pituitary Tumours
Condition: Pituitary Tumours
Intervention: Procedure: Gallium-68 DOTATOC PET
3 Not yet recruiting Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
Conditions: Pituitary Tumor;   ACTH-producing Pituitary Tumour
Intervention: Drug: Pasireotide LAR
4 Recruiting Effects of Hormone Stimulation on Brain Scans for Cushing s Disease
Condition: Pituitary Neoplasm
Intervention: Drug: Acthrel
5 Recruiting Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland
Condition: Pituitary Neoplasms
Intervention: Device: da Vinci® Si™
6 Recruiting Effects of Total Intravenous Anesthesia With Propofol-remifentanil Versus Inhalational Anesthesia With Sevoflurane on Quality of Recovery in Patients Undergoing Transsphenoidal Surgery for Pituitary Tumor
Condition: Pituitary Tumor
Interventions: Drug: total intravenous anesthesia (TIVA);   Drug: inhalation anesthesia group
7 Recruiting PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon
Condition: Pituitary Tumor
Intervention:
8 Recruiting Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
Conditions: Pituitary Neoplasms;   Adenoma
Intervention: Drug: cabergoline
9 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
10 Recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Conditions: Abnormalities;   Craniopharyngioma;   Cushing's Syndrome;   Endocrine Disease;   Pituitary Neoplasm
Intervention:
11 Recruiting Intraoperative Imaging of Pituitary Adenomas by OTL
Conditions: Neoplasms;   Pituitary Neoplasms
Intervention: Drug: OTL38
12 Recruiting Evaluation of Patients With Endocrine-Related Conditions
Conditions: Adrenal Insufficiency;   Pituitary Neoplasm;   Obesity
Intervention:
13 Recruiting Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Conditions: Pituitary Adenomas;   Prolactinomas
Intervention: Drug: Lapatinib
14 Recruiting Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Conditions: Pituitary Adenoma;   Pituitary Tumor
Interventions: Procedure: Surgical intervention for CNFA;   Radiation: Radiotherapy for CNFA
15 Recruiting Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Conditions: Pituitary Neoplasms;   Prolactinoma;   ACTH-Secreting Pituitary Adenoma;   Gigantism;   Growth Hormone-Secreting Pituitary Adenoma
Intervention: Other: Educational Intervention
16 Recruiting Omega-3 Supplementation for Smell Dysfunction
Conditions: Sellar/Parasellar Tumor;   Smell Dysfunction
Intervention: Dietary Supplement: Omega-3
17 Recruiting A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma
Condition: Patients Presenting With Suspected Malignancies of the Pituitary Gland
Interventions: Drug: OTL0038;   Drug: Benadryl;   Device: intraoperative imaging
18 Recruiting Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests
Condition: Pituitary Adenoma
Interventions: Drug: Sevoflurane;   Drug: Desflurane;   Drug: Propofol
19 Recruiting Transsphenoidal Extent of Resection Study
Condition: Pituitary Adenoma
Intervention: Procedure: transsphenoidal surgery
20 Recruiting Evaluate the Efficacy and Safety of Pasireotide LAR on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.
Condition: Non-functioning Pituitary Adenoma
Intervention: Drug: Pasireotide LAR

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.